One patient with brain cancer and another with liver cancer survived more than five years without recurrence after receiving personalized cancer vaccines.

Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

SomeDNASequence 0 acttttctgt ggctacatat atatatgcaa aagacaaaag ataacccagt 50 taaatagtac tattttgtgt caatctcctc atcgatctca ttttgtctct 100 gattagagct tcaaaatgga taccggtgaa ggtaagtcag cacaagcacc 150 ...